$SNPS

Kankanwadi Sudhindra sold $6.0M of SNPS

Kankanwadi Sudhindra (Deputy CFO & CAO) sold 12,170 shares of SYNOPSYS INC (SNPS) at an average of $496.25 ($484.78–$500.00, $6.04M total) across 2 trades over 2026-10-05 to 2026-10-06.

Original reporting
SEC EDGAR · Kankanwadi Sudhindra
Published Oct 6, 2026, 11:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 11:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNPS
Bearish
medium confidence
Mentioned
$SNPS
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNPSBearishLow
01

Why it matters

The disclosed sale provides fresh data on insider holdings, which can affect short‑term trading decisions.

02

Market read

A sizable insider sell by a senior executive may trigger short‑term price pressure, though the overall impact on the sector is limited.

03

What to watch

No 10b5‑1 plan and the sale occurred over two days, suggesting possible strategic timing.

Relevance 6/10Novelty 5/10Timing: after‑hours filing

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.

Company-level read

Ticker impact

$SNPSBearishMedium confidence
Context

Deputy CFO & CAO Kankanwadi Sudhindra sold 12,170 shares of Synopsys for $6.0M, reducing his stake to 22,717 shares.

Expected impact

likely downward pressure as the market prices in the insider sell

Evidence & confidence

A $6M sale by a C‑suite officer is a material insider transaction that can influence short‑term sentiment.

Market effects

Minimal impact on the broader software/EDA sector; only affects Synopsys perception.

U.S. market only; no regional ripple.

Low; limited to investors tracking insider activity.

Counterpoint

The sale could be a routine portfolio rebalancing unrelated to company outlook.

Key entities

  • Synopsys Inc.

    U.S. listed software and semiconductor design automation firm (ticker SNPS).

  • Kankanwadi Sudhindra

    Deputy CFO & Chief Accounting Officer of Synopsys.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SNPSMed

Why Should You Think About Synopsys Differently Now?

Synopsys (SNPS) trades at 80.8x P/E, focusing on AI-driven chip design and Ansys. Its IP business, which underperformed due to export restrictions and customer challenges, returned to growth in Q3 2026. Ansys revenue was 1.5x Design IP's revenue in the same quarter. Management highlights a shift to a licensing-plus-royalties model, with a $1B+ deal with Amazon.

$SNPSMed

S&P lifts Synopsys to ’BBB+’ as chip-design leader capitalizes on AI demand

S&P Global Ratings upgraded Synopsys Inc's credit rating to 'BBB+' from 'BBB', citing strong long-term growth prospects driven by AI demand. The company expects mid-teens revenue growth through 2029 and improved profitability, with 2029 EBITDA margin projected at 49%. Synopsys is also accelerating cost synergies from its Ansys acquisition and expanding commercial traction, including a $1B+ contract with Amazon.

$AMZNMedAI 8/10

Amazon and Synopsys seal $1bn technology partnership

Amazon and Synopsys have signed a $1 billion deal to accelerate Amazon's custom silicon innovation and advance AI products and cloud infrastructure. The multi-year agreement builds on 15 years of collaboration, with Synopsys providing application-optimized silicon IP. Amazon's Peter DeSantis highlighted the impact of custom silicon on AWS, while Synopsys' Sassine Ghazi emphasized the partnership's role in shaping AI-native engineering.

$SNPSMed

Morgan Stanley Thinks Synopsys’ AI Story Isn’t Priced In

Morgan Stanley raised its price target for Synopsys to $574 from $500, forecasting fiscal 2027 EPS of $19.12. The firm believes Synopsys' AI story isn't fully priced in, but a re-rating depends on execution and proof of usage revenue growth. Investors will watch for metrics like customer retention and contracted backlog.